Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Vetoquinol SA (Vetoquinol), a subsidiary of Soparfin SCA, is a veterinary pharmaceutical company that develops, produces, and distributes veterinary drugs and non-medicinal products for all animals, especially for cats, dogs, cattle, and pigs. The company offers products in therapy areas which include pain, mobility, and inflammation; dermatology, hygiene, and care; udder health; anti-parasite; antibiotics; reproduction; internal medicine; cardio-nephrology; and behavior management. It also offers diagnostics, digital applications, and services. The company distributes its products under brands such as Tolfedine CS, Clindaseptin, Aurizon, Oridermyl, Longamox, and Pen-Histra-Strep, among others to customers, veterinarians, breeders, and pet owners in Europe; the Americas; Africa; Middle East; Asia; and Oceania. Vetoquinol is headquartered in Lure, France.

Gain a 360-degree view of Vetoquinol SA and make more informed decisions for your business Gain a 360-degree view of Vetoquinol SA and make more informed decisions for your business Contact Us
Headquarters France

Address Sainte-Anne 34 Rue Du Chene, Bp 189, Lure Cedex, Haute Normandie, 70204


Telephone 33 3 84625555

No of Employees 2,483

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange VETO (EPA)

Revenue (2022) $572.4M -1.9% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ 15.8% (2022 vs 2021)

Market Cap* $1.3B

Net Profit Margin (2022) XYZ 18.1% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Vetoquinol SA premium industry data and analytics

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Vetoquinol SA’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Domains: Tolfedine CS
Mobility, Pain, and Inflammation Tolfine
Dermatology, Hygiene & Care Cimalgex
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Vetoquinol SA portfolio and identify potential areas for collaboration Understand Vetoquinol SA portfolio and identify potential areas for collaboration Contact Us

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 New Products/Services In March, the company launched VetPowerment, an employee engagement and development tool.
2022 Acquisitions/Mergers/Takeovers In May, the company acquired Cattle-Mate and Ovu-Late.
2022 Acquisitions/Mergers/Takeovers In May, the company acquired Phovia product business from Klox Technologies. Ltd.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Contact Us
Image for loader

Competitor Comparison

Key Parameters Vetoquinol SA Ceva Sante Animale SA Virbac Group Kindred Biosciences Inc LABIANA Group
Headquarters France France France United States of America Spain
City Lure Libourne Carros Burlingame Terrassa
State/Province Haute Normandie Aquitaine - California Barcelona
No. of Employees 2,483 6,300 5,459 - -
Entity Type Public Private Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Matthieu Frechin Director; Chairman; Chief Executive Officer Executive Board 2023 -
Re Gis Vimal Du Monteil Chief Financial Officer Senior Management - -
Dominique Derveaux Chief Operating Officer Senior Management - -
Sandrine Perrier Chief Information Officer Senior Management - -
Stephane Villemin Group Director - Medical and Marketing Department Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Vetoquinol SA key executives to enhance your sales strategy Gain insight into Vetoquinol SA key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer